A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

NCT00606177 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Aripiprazole
DRUG: placebo

Sponsor

Otsuka Pharmaceutical Co., Ltd.